Eaton Vance Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Eaton Vance Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-339	Closed	-$21K	–	1855
2021 Q4	$21K	Sell	339 -10	-3%	-$691	﹤0.01%	2379
2021 Q3	$0	Sell	349 -100	-22%	-$8.39K	﹤0.01%	2026
2021 Q2	$41K	Sell	449 -218	-33%	-$18.5K	﹤0.01%	2221
2021 Q1	$59K	Buy	+667	New	+$66.2K	﹤0.01%	1746

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Eaton Vance Management's ARKG Position: Q1 2022 in Review

Eaton Vance Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 339 shares — an estimated $21K sold.

Eaton Vance Management first reported a position in ARKG in Q1 2021 and held it in 4 quarters. The position peaked at $59K in Q1 2021. 388 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Eaton Vance Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Eaton Vance Management sold 339 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $21K.
Eaton Vance Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 4 quarters.
Eaton Vance Management's ARK Genomic Revolution ETF position peaked at $59K in Q1 2021.
388 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.